- Home
- TCRT vs ALBT Comparison
TCRT vs ALBT Comparison
Compare TCRT & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- ALBT
- Stock Information
- Founded
- TCRT 1998
- ALBT 2014
- Country
- TCRT United States
- ALBT United States
- Employees
- TCRT N/A
- ALBT N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCRT Health Care
- ALBT Health Care
- Exchange
- TCRT Nasdaq
- ALBT Nasdaq
- Market Cap
- TCRT 3.8M
- ALBT 3.2M
- IPO Year
- TCRT N/A
- ALBT N/A
- Fundamental
- Price
- TCRT $2.08
- ALBT $3.15
- Analyst Decision
- TCRT
- ALBT
- Analyst Count
- TCRT 0
- ALBT 0
- Target Price
- TCRT N/A
- ALBT N/A
- AVG Volume (30 Days)
- TCRT 14.2K
- ALBT 2.0M
- Earning Date
- TCRT 11-14-2024
- ALBT 11-12-2024
- Dividend Yield
- TCRT N/A
- ALBT N/A
- EPS Growth
- TCRT N/A
- ALBT N/A
- EPS
- TCRT N/A
- ALBT N/A
- Revenue
- TCRT $7,000.00
- ALBT N/A
- Revenue This Year
- TCRT N/A
- ALBT N/A
- Revenue Next Year
- TCRT N/A
- ALBT N/A
- P/E Ratio
- TCRT N/A
- ALBT N/A
- Revenue Growth
- TCRT N/A
- ALBT N/A
- 52 Week Low
- TCRT $1.95
- ALBT $2.11
- 52 Week High
- TCRT $33.00
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- TCRT 44.32
- ALBT 49.01
- Support Level
- TCRT $2.00
- ALBT $2.97
- Resistance Level
- TCRT $2.86
- ALBT $3.69
- Average True Range (ATR)
- TCRT 0.17
- ALBT 0.50
- MACD
- TCRT 0.05
- ALBT 0.01
- Stochastic Oscillator
- TCRT 14.29
- ALBT 40.31
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.